A new drug that claims to boost the walking speed of people with multiple sclerosis (MS) by 25 per cent has been launched this week.
Fampyra is only the second licensed symptom relief treatment ever for MS but it is still unclear if PCTs and local healthcare authorities will provide funds for the treatment.
Yesterday Dr Jayne Spink, director of policy and research at the MS Society, stated that the new drug is "really welcome news for people with MS" and it is hoped that local authorities and PCTs will make the drug available for all those who need it.
"While the treatment doesn't alter the progression of the condition, it does treat the symptoms and may greatly improve walking speed – which enables people to have more independence," Dr Spink continued.
As a part of the MS Society's agenda to campaign for change, they will no doubt be lobbying to ensure that supplies of Fampyra become readily available.
The MS Society also provides funding for research, grants and information and support for people with MS.
Read about Barchester expertise in offering multiple sclerosis support.